Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07148999 · ClinicalTrials.gov registry record · Phase 1
An Advanced Decision Support Tool for Personalized Medicine for IVF Using Modeling and Optimization for Provera
A Phase 1 study of Infertility (IVF Patients), sponsored by Urmila DIwekar.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 200
- Enrollment target
- 2
- Study locations
NCT07148999: Recruiting Phase 1 study of Infertility (IVF Patients), sponsored by Urmila DIwekar.
NCT07148999 is a Phase 1 study of Infertility (IVF Patients) that is actively recruiting participants, run by Urmila DIwekar. The registered enrollment target is 200 participants, below the 457-participant average among 9 other Infertility (IVF Patients) trials with a reported enrollment target (56% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07148999, a Phase 1 study of Infertility (IVF Patients), is actively recruiting participants, sponsored by Urmila DIwekar.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 200 participants
- Enrollment target
- 2
- Study locations
Study Summary
A clinical trial will determine the effectiveness of using the Opt-IVF decision support tool for each patient's personalized and optimal drug dosage profile in the United States.
Primary Outcome
Total Gonadotropin Dosage for the cycle
Conditions Studied
Interventions
- OTHER Control
- COMBINATION_PRODUCT Opt-IVF
Study Locations (2)
Texas
- Positivf Fertility - Houston
- Positivf Fertility - San Antonio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2025-09-23 |
| Est. Completion | 2026-02-15 |
| Phase | Phase 1 |
What NCT07148999 shows while recruiting
NCT07148999 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 457-participant average among 9 other Infertility (IVF Patients) trials with a reported enrollment target (56% lower).
The record links to 1 condition, with Infertility (IVF Patients) appearing as the primary indexed condition, and to 2 interventions - of which Control is the first listed.
NCT07148999 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT07148999 about?
NCT07148999 is a clinical study titled "An Advanced Decision Support Tool for Personalized Medicine for IVF Using Modeling and Optimization for Provera". A clinical trial will determine the effectiveness of using the Opt-IVF decision support tool for each patient's personalized and optimal drug dosage profile in the United States.
What is the current status of trial NCT07148999?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 200 participants. The study started on 2025-09-23. Estimated completion is 2026-02-15.
What conditions does trial NCT07148999 study?
This clinical trial studies the following conditions: Infertility (IVF Patients).
What interventions are being tested in trial NCT07148999?
The interventions under investigation include: Control (OTHER), Opt-IVF (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT07148999?
This trial is sponsored by Urmila DIwekar, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07148999 being conducted?
This trial has 2 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Infertility (IVF Patients)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07148999's enrollment target sits among peer trials
200 6th of 9 higher than 3 of 9 other Infertility (IVF Patients) trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Infertility (IVF Patients) trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Quantifying Uterine Elastography in Menstruating Women
RECRUITING
-
The EPIC Study: Exploring Paternal Age and the Influence on Blastocyst Culture
RECRUITING · NA
-
Cleavage-stage Versus Blastocyst-stage Embryo Transfer in IVF Patients With Few Embryos
RECRUITING · Phase 3
-
Human Menopausal Gonadotropin Research in Infertility Assessing Cumulative Live Birth With Frozen Embryo Transfer.
RECRUITING · Phase 3
-
Male Infertility and Assisted Reproductive Technologies Research Biobank
RECRUITING
-
Ketorolac Use and Fresh Embryo Transfer Outcomes
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI